Stay updated on Somapacitan vs Norditropin in Growth Hormone Deficiency Clinical Trial

Sign up to get notified when there's something new on the Somapacitan vs Norditropin in Growth Hormone Deficiency Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Somapacitan vs Norditropin in Growth Hormone Deficiency Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The clinical trial record is displayed, describing a completed Phase 3 comparison of once-weekly somapacitan and daily somatropin in adults with growth hormone deficiency, with study design, eligibility, outcomes, and location details.
    Difference
    51%
    Check dated 2026-11-07T12:19:36.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer now identifies the ClinicalTrials.gov site as revision v3.8.0 instead of v3.7.2. The page still displays a 403 Forbidden error rather than the study record.
    Difference
    0.2%
    Check dated 2026-10-31T12:54:14.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to transition updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T13:32:24.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changes from v3.7.1 to v3.7.2. The page continues to display a 403 error rather than the study record.
    Difference
    0.2%
    Check dated 2026-10-17T13:34:03.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1; the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T14:33:45.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error, replacing the ClinicalTrials.gov study record content with a generic error page. This indicates the study details are temporarily inaccessible.
    Difference
    16%
    Check dated 2026-09-19T19:21:01.000Z thumbnail image

Stay in the know with updates to Somapacitan vs Norditropin in Growth Hormone Deficiency Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Somapacitan vs Norditropin in Growth Hormone Deficiency Clinical Trial page.